Back to news

Cameco Jumps as Investors Focus on New U.S. Reactor Framework and Nuclear Demand Tailwinds

Investivoq PriceTracker

Cameco (CCJ) is up 7.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied mainly to renewed investor interest after Cameco highlighted a new U.S.-South Korea framework that could support deployment of up to eight large reactors in the United States, including Westinghouse technology in which Cameco has an economic interest. Strength in the broader nuclear fuel outlook likely added support, as Cameco has recently pointed to improving uranium pricing and long-term demand fundamentals.

Details:

  • Cameco said on September 30 that the U.S. and South Korea announced a framework contemplating up to US$120 billion to help finance the buildout of Westinghouse reactor technology in the U.S.
  • The framework outlines potential construction of up to eight large reactors in the U.S., including six AP1000 units and up to two APR1400 units built on Westinghouse technology.
  • Cameco has said previously that Westinghouse is seeing a large pipeline of reactor opportunities, which could create follow-on value for Westinghouse as well as Cameco’s uranium and fuel services businesses.
  • In its latest quarterly update, Cameco also raised parts of its uranium-segment outlook to reflect a higher UxC spot price, reinforcing the view that improving fuel market conditions may be helping sentiment.
  • Sources:

    Cameco, SEC, AP News

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    Investivoq Alerts
    Receive CCJ Data Alerts
    Get market-moving data, filings, and signals for CCJ in real time.
    Sign Up

    $CCJ Hedge Fund Activity

    We have seen 472 institutional investors add shares of $CCJ stock to their portfolio, and 431 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • JPMORGAN CHASE & CO added 4,198,623 shares (+inf%) to their portfolio in Q2 2026, for an estimated $427,671,738
    • D. E. SHAW & CO., INC. added 1,801,963 shares (+3445.4%) to their portfolio in Q2 2026, for an estimated $183,547,951
    • CANADA PENSION PLAN INVESTMENT BOARD added 1,660,691 shares (+67.3%) to their portfolio in Q2 2026, for an estimated $169,157,985
    • ARISTOTLE CAPITAL MANAGEMENT, LLC removed 1,637,107 shares (-60.8%) from their portfolio in Q2 2026, for an estimated $166,755,719
    • MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 1,421,799 shares (+49.5%) to their portfolio in Q2 2026, for an estimated $144,824,446
    • CASTLE HOOK PARTNERS LP removed 1,388,052 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $141,386,976
    • BANK OF MONTREAL /CAN/ added 1,354,382 shares (+22.5%) to their portfolio in Q2 2026, for an estimated $137,957,350

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $CCJ Analyst Ratings

    Wall Street analysts have issued reports on $CCJ in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • William Blair issued a "Outperform" rating on 04/20/2026

    To track analyst ratings and price targets for $CCJ, check out Investivoq's $CCJ forecast page.

    $CCJ Price Targets

    Multiple analysts have issued price targets for $CCJ recently. We have seen 3 analysts offer price targets for $CCJ in the last 6 months, with a median target of $140.0.

    Here are some recent targets:

    • Lawson Winder from B of A Securities set a target price of $140.0 on 07/09/2026
    • Andrew D. Wong from RBC Capital set a target price of $175.0 on 06/29/2026
    • Richard Garchitorena from Barclays set a target price of $108.0 on 05/22/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.